Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#pomalidomide ×

Regulatory Updates

Sep 24, 2026•1 min read

FDA Approves ANDA210245 for Pomalidomide Oral Capsules

The FDA has approved ANDA210245 submitted by MSN for generic pomalidomide capsules in 2 mg, 3 mg, and 4 mg strengths.